期刊
FRONTIERS IN IMMUNOLOGY
卷 7, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2016.00274
关键词
MUC5B; MUC2; cytokines; idiopathic pulmonary fibrosis; sequenom MassARRAY; single nucleotide polymorphism; association study; network analysis
类别
资金
- National Strategic Reference Framework (Greece) [09SYN-12-680]
- Hellenic scientific society for rare diseases and orphan drugs
- [CZ.1.07/2.3.00/30.0041]
- [LO1304]
- [IGA_PU_LF_2015_020]
- [2016_009]
Idiopathic pulmonary fibrosis (IPF) affects lung parenchyma with progressing fibrosis. In this study, we aimed to replicate MUC5B rs35705950 variants and determine new plausible candidate variants for IPF among four different European populations. We genotyped 26 IPF candidate loci in 165 IPF patients from four European countries, such as Czech Republic (n = 41), Germany (n = 33), Greece (n = 40), France (n = 51), and performed association study comparing observed variant distribution with that obtained in a genetically similar Czech healthy control population (n = 96) described in our earlier data report. A highly significant association for a promoter variant (rs35705950) of mucin encoding MUC5B gene was observed in all IPF populations, individually and combined [odds ratio (95% confidence interval); p-value as 5.23 (8.943.06); 1.80 X 10-11]. Another non-coding variant, rs7934606 in MUC2 was significant among German patients [2.85 (5.051.60); 4.03 X 10-4] and combined European IPF cases [2.18 (3.161.50); 3.73 X 10-5]. The network analysis for these variants indicated genegene and genephenotype interactions in IPF and lung biology. With replication of MUC5B rs35705950 previously reported in U.S. populations of European descent and indicating other plausible polymorphic variants relevant for IPF, we provide additional reference information for future extended functional and population studies aimed, ideally with inclusion of clinical parameters, at identification of IPF genetic markers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据